Audiologic Assessment and Management of Teprotumumab-Associated Ototoxicity: An Updated Narrative Review

Audiologists should implement proactive baseline and monitoring audiologic assessments for patients prescribed teprotumumab, as ototoxicity risk is well-documented; this review provides updated clinical guidance on assessment and management strategies.